7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (σ2) receptor ligands

Bioorg Med Chem Lett. 2012 Jun 15;22(12):4059-63. doi: 10.1016/j.bmcl.2012.04.077. Epub 2012 Apr 30.

Abstract

A series of N-substituted 7-azabicyclo[2.2.1]heptanes (12-17 and 22-25) and similarly substituted pyrrolidines (32-36 and 41-44) were synthesized as sterically-reduced, achiral analogs of adamantane- and trishomocubane-derived σ ligands. In vitro competition binding assays against σ receptors revealed that arylalkyl N-substituents conferred selectivity for the σ(2) subtype, while alicyclic or polycarbocyclic substituents imparted high affinity for both subtypes. The σ(2) binding and subtype selectivities of N-arylalkyl-7-azanorbornanes was generally greater than the analogously-substituted pyrrolidines, indicating that steric bulk and conformational restriction around the nitrogen atom are likely important for subtype discrimination.

MeSH terms

  • Adamantane / chemistry
  • Animals
  • Antipsychotic Agents / chemical synthesis*
  • Antipsychotic Agents / pharmacology
  • Azabicyclo Compounds / chemical synthesis*
  • Azabicyclo Compounds / pharmacology
  • Binding, Competitive
  • Brain Chemistry
  • Heptanes / chemical synthesis*
  • Heptanes / pharmacology
  • Humans
  • Kinetics
  • Ligands
  • Molecular Structure
  • Nitrogen / chemistry
  • Protein Binding
  • Pyrrolidines / chemical synthesis*
  • Pyrrolidines / pharmacology
  • Radioligand Assay
  • Rats
  • Receptors, sigma / metabolism*
  • Structure-Activity Relationship
  • Tissue Extracts / metabolism

Substances

  • Antipsychotic Agents
  • Azabicyclo Compounds
  • Heptanes
  • Ligands
  • Pyrrolidines
  • Receptors, sigma
  • Tissue Extracts
  • sigma-2 receptor
  • Nitrogen
  • Adamantane